Lorlatinib For Advanced Ros1+Non-Small Cell Lung Cancer (Nsclc): Efficacy And Safety Data From Ifct-1803 Lorlatu Expanded Access Program (Eap) CohortN. Girard,S. Galland Girodet,M. Duruisseaux,V. Avrillon,B. Roch,J. Otto, J. Cadranel, M. Coudurier,D. Moro-Sibilot, T. Egenod, R. Lamy,J. Bennouna,G. Zalcman,C. Ricordel, J. Tillon, L. Odier,B. Besse,P. Missy,V. Westeel,S. BaldacciANNALS OF ONCOLOGY（2020）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
